Cargando…
Evaluation of Multiple Methods for Quantification of Glycosaminoglycan Biomarkers in Newborn Dried Blood Spots from Patients with Severe and Attenuated Mucopolysaccharidosis-I
All newborn screening (NBS) for mucopolysaccharidosis-I (MPS-I) is carried out by the measurement of α-iduronidase (IDUA) enzymatic activity in dried blood spots (DBS). The majority of low enzyme results are due to pseudodeficiencies, and studies from the Mayo Clinic have shown that the false positi...
Autores principales: | Herbst, Zackary M., Urdaneta, Leslie, Klein, Terri, Fuller, Maria, Gelb, Michael H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7570209/ https://www.ncbi.nlm.nih.gov/pubmed/33123640 http://dx.doi.org/10.3390/ijns6030069 |
Ejemplares similares
-
Evaluation of Two Methods for Quantification of Glycosaminoglycan Biomarkers in Newborn Dried Blood Spots from Patients with Severe and Attenuated Mucopolysaccharidosis Type II
por: Herbst, Zackary M., et al.
Publicado: (2022) -
High-Throughput Liquid Chromatography–Tandem Mass Spectrometry Quantification of Glycosaminoglycans as Biomarkers of Mucopolysaccharidosis II
por: Wang, Junhua, et al.
Publicado: (2020) -
Development of a newborn screening tool for mucopolysaccharidosis type I based on bivariate normal limits: Using glycosaminoglycan and alpha‐L‐iduronidase determinations on dried blood spots to predict symptoms
por: Langan, Thomas J., et al.
Publicado: (2020) -
The Interplay of Glycosaminoglycans and Cysteine Cathepsins in Mucopolysaccharidosis
por: David, Alexis, et al.
Publicado: (2023) -
Newborn Screening for Mucopolysaccharidosis I: Moving Forward Learning from Experience
por: Clarke, Lorne A., et al.
Publicado: (2020)